national shortage of semaglutide FDA ends shortage, closing the door on compounded Wegovy, Ozempic Semaglutide Injections and the FDA
Description
Overall, oral semaglutide compared favorably in terms of the efficacy endpoints examined
However, as in every study, this work is not exempt from limitations
Definitely, the share of the population is massively expanding
The diversity of approaches suggests that, unlike the GLP-1 market, which is dominated by a single mechanism, the hair loss space could see multiple competing modalities
